1.76 USD
▼-0.18-9.28%
盘后 2.39 0.00%
2026-09-16
市值
$2.80M
市盈率
—
EPS
-5.07
股息率
—
52 周区间
1.63 – 15.15
成交量
79.14K
Beta
0.75
目标价
—
52W 低 1.6352W 高 15.15
价格走势
公司简介
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a ...